Cargando…
Needleless Ablation of Osteoid Osteoma and Osteoblastoma: The Emergent Role of MRgFUS
Osteoblastoma (OB) and osteoid osteoma (OO) are benign bone-forming tumors, with nearly identical basic microscopic features. The main difference is dimension (OO has usually a nidus measuring <2 cm in diameter). In addition, OB is biologically more active than OO, with a tendency to grow in size...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745067/ https://www.ncbi.nlm.nih.gov/pubmed/35011867 http://dx.doi.org/10.3390/jcm11010128 |
_version_ | 1784630255876571136 |
---|---|
author | Cobianchi Bellisari, Flavia Palumbo, Pierpaolo Masciocchi, Carlo Zoccali, Carmine Barile, Antonio Arrigoni, Francesco |
author_facet | Cobianchi Bellisari, Flavia Palumbo, Pierpaolo Masciocchi, Carlo Zoccali, Carmine Barile, Antonio Arrigoni, Francesco |
author_sort | Cobianchi Bellisari, Flavia |
collection | PubMed |
description | Osteoblastoma (OB) and osteoid osteoma (OO) are benign bone-forming tumors, with nearly identical basic microscopic features. The main difference is dimension (OO has usually a nidus measuring <2 cm in diameter). In addition, OB is biologically more active than OO, with a tendency to grow in size. Historically, treatments have included surgical resection and analgesics, although invasiveness and poor tolerance have led to the current standard of care moving toward interventional radiology, where radiofrequency ablation (RFA) represents the most diffuse technique. Magnetic resonance-guided focused ultrasound surgery (MRgFUS) has recently emerged as another innovative alternative treatment, providing tumor ablation through a needleless and ionizing radiation-free modality. In addition, this technique has the ability to guarantee a very precise and controlled increase in temperature, delivering small amounts of energy that can accurately destroy only the lesion, avoiding healthy surrounding tissues. The present review focuses on MRgFUS as the less invasive, safe, effective, and durable treatment option for the management of osteoid osteoma and osteoblastoma, including a description of technical details, indications and outcomes. |
format | Online Article Text |
id | pubmed-8745067 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87450672022-01-11 Needleless Ablation of Osteoid Osteoma and Osteoblastoma: The Emergent Role of MRgFUS Cobianchi Bellisari, Flavia Palumbo, Pierpaolo Masciocchi, Carlo Zoccali, Carmine Barile, Antonio Arrigoni, Francesco J Clin Med Review Osteoblastoma (OB) and osteoid osteoma (OO) are benign bone-forming tumors, with nearly identical basic microscopic features. The main difference is dimension (OO has usually a nidus measuring <2 cm in diameter). In addition, OB is biologically more active than OO, with a tendency to grow in size. Historically, treatments have included surgical resection and analgesics, although invasiveness and poor tolerance have led to the current standard of care moving toward interventional radiology, where radiofrequency ablation (RFA) represents the most diffuse technique. Magnetic resonance-guided focused ultrasound surgery (MRgFUS) has recently emerged as another innovative alternative treatment, providing tumor ablation through a needleless and ionizing radiation-free modality. In addition, this technique has the ability to guarantee a very precise and controlled increase in temperature, delivering small amounts of energy that can accurately destroy only the lesion, avoiding healthy surrounding tissues. The present review focuses on MRgFUS as the less invasive, safe, effective, and durable treatment option for the management of osteoid osteoma and osteoblastoma, including a description of technical details, indications and outcomes. MDPI 2021-12-27 /pmc/articles/PMC8745067/ /pubmed/35011867 http://dx.doi.org/10.3390/jcm11010128 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Cobianchi Bellisari, Flavia Palumbo, Pierpaolo Masciocchi, Carlo Zoccali, Carmine Barile, Antonio Arrigoni, Francesco Needleless Ablation of Osteoid Osteoma and Osteoblastoma: The Emergent Role of MRgFUS |
title | Needleless Ablation of Osteoid Osteoma and Osteoblastoma: The Emergent Role of MRgFUS |
title_full | Needleless Ablation of Osteoid Osteoma and Osteoblastoma: The Emergent Role of MRgFUS |
title_fullStr | Needleless Ablation of Osteoid Osteoma and Osteoblastoma: The Emergent Role of MRgFUS |
title_full_unstemmed | Needleless Ablation of Osteoid Osteoma and Osteoblastoma: The Emergent Role of MRgFUS |
title_short | Needleless Ablation of Osteoid Osteoma and Osteoblastoma: The Emergent Role of MRgFUS |
title_sort | needleless ablation of osteoid osteoma and osteoblastoma: the emergent role of mrgfus |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745067/ https://www.ncbi.nlm.nih.gov/pubmed/35011867 http://dx.doi.org/10.3390/jcm11010128 |
work_keys_str_mv | AT cobianchibellisariflavia needlelessablationofosteoidosteomaandosteoblastomatheemergentroleofmrgfus AT palumbopierpaolo needlelessablationofosteoidosteomaandosteoblastomatheemergentroleofmrgfus AT masciocchicarlo needlelessablationofosteoidosteomaandosteoblastomatheemergentroleofmrgfus AT zoccalicarmine needlelessablationofosteoidosteomaandosteoblastomatheemergentroleofmrgfus AT barileantonio needlelessablationofosteoidosteomaandosteoblastomatheemergentroleofmrgfus AT arrigonifrancesco needlelessablationofosteoidosteomaandosteoblastomatheemergentroleofmrgfus |